Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program ...

Lantern Pharma Inc. (Nasdaq: LTRN), an artificial intelligence company developing targeted and transformative cancer ...

In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...

Bicara Therapeutics Inc. announced that new data from their ongoing Phase 1/1b clinical trial of ficerafusp alfa, a first-in-class bifunctional antibody, will be presented orally at the 2025 ASCO ...

About the TUPELO Trial Design (REC-4881) The Phase 1b/2 TUPELO trial is evaluating the safety, tolerability, pharmacokinetics ...

BEVERLY, Mass.--(BUSINESS WIRE)--Glycologix, Inc. (“Glycologix”), a clinical-stage company developing biopolymers for the protection and repair of soft tissues, announced that clinical results ...

EnteroBiotix to present results from IMPuLCE phase 1b trial of EBX-102 in patients with liver cirrhosis at EASL Congress 2025: Glasgow, Scotland Monday, May 5, 2025, 13:00 Hrs [IS ...

Therini Bio reveals promising Phase 1a trial results for THN391, a potential breakthrough treatment for neurodegenerative ...

Rein previously announced positive topline results from Cohort 2 (5 mg BID) of the Phase 1b clinical trial of LTI-03 in IPF, in which a positive trend was observed in seven out of eight biomarkers ...